Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 8,677-8,688 of 23,847
Drug study icon
CompletedNCT01624649

A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors

This study exists to learn from real-world information that can show how a medication treatment fits into care. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Bucheon-Si Gyeonggi-Do
ADHDDrugFrom 6 Years to 15 Years
Countries
South Korea
Sponsor
Janssen Korea, Ltd., Korea
Condition
ADHD
Drug study icon
CompletedNCT01829048

Safety study of PF-02545920 in schizophrenia

This study is completed in the United States. It is testing PF-02545920 for schizophrenia.

In Glendale
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Pfizer
Condition
Schizophrenia
Drug study icon
CompletedNCT01518894

Safety study of PF-04958242 in schizophrenia

This study is completed in the United States. It is testing PF-04958242 for schizophrenia.

In Long Beach
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Biogen
Condition
Schizophrenia
Drug study icon
CompletedNCT01880099

A Study to Help People Quit Smoking.

This summary needs review. Please check the official study record and contact the research team for details.

In West Haven
AddictionDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Yale University
Condition
Addiction
Drug study icon
CompletedNCT00224510

A Study To Investigate The Antidepressant Effect Of Lamotrigine In people with Bipolarity Using Lithium

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can better prevent setbacks and support longer-term stability.

Multiple locations, including Alkmaar
Bipolarity, DepressionDrugOver 18 Years
Countries
Netherlands, Spain
Sponsor
GlaxoSmithKline
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT02281773

Four Different Doses of BI 409306 Compared to Placebo Given for schizophrenia

This study is completed in the United States, in Canada, in Germany, .... It is testing Four Different Doses of BI 409306 Compared to Placebo Given for schizophrenia.

Multiple locations, including Little Rock
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States, Canada, Germany, ...
Sponsor
Boehringer Ingelheim
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.